Loading...
Tranexamic acid reduces blood loss after primary shoulder arthroplasty: a double-blind, placebo-controlled, prospective, randomized controlled trial
BACKGROUND: Tranexamic acid (TXA) is an antifibrinolytic that has been shown to decrease blood loss and transfusion rates after hip and knee arthroplasty, with only limited evidence to support its use in shoulder arthroplasty. This study was conducted to determine whether intravenous (IV) TXA is mor...
Na minha lista:
| Udgivet i: | JSES Open Access |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6334853/ https://ncbi.nlm.nih.gov/pubmed/30675563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jses.2018.01.002 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|